Risk factors for COVID-19 infection in people with 4th dose of bivalent mRNA vaccines in general medicine from October 2022 to February 2023
<p>Background: Risk factors of COVID-19 infection in people vaccinated with the 4th dose of mRNA COVID-19 vaccine remain the subject of debate.</p><p>Objective: To identify risk and protective factors of COVID-19 in vaccinated people with 4th dose of bivalent mRNA vaccines.</p&g...
Saved in:
Main Author: | Jose Luis Turabian (Author) |
---|---|
Format: | Book |
Published: |
Archives of Community Medicine and Public Health - Peertechz Publications,
2023-05-30.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors and incidence rates of COVID-19 breakthrough infections in vaccinated people with vaccine booster in general medicine, Toledo (Spain), for the period December 2021 to February 2022
by: Jose Luis Turabian
Published: (2022) -
Comparative 60-day effectiveness of bivalent versus monovalent mRNA vaccines in Shelby County: a population-level analysis
by: Allison P. Plaxco, et al.
Published: (2024) -
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
by: Bradley K. Ackerson, et al.
Published: (2024) -
mRNA as a Therapeutics: Understanding mRNA Vaccines
by: Ferdi Oğuz, et al.
Published: (2022) -
Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
by: Abdulbaril Olagunju MD, et al.
Published: (2022)